BR0212429A - Uso de hcg na hiperestimulação ovariana controlada - Google Patents

Uso de hcg na hiperestimulação ovariana controlada

Info

Publication number
BR0212429A
BR0212429A BR0212429-7A BR0212429A BR0212429A BR 0212429 A BR0212429 A BR 0212429A BR 0212429 A BR0212429 A BR 0212429A BR 0212429 A BR0212429 A BR 0212429A
Authority
BR
Brazil
Prior art keywords
hcg
ovarian hyperstimulation
controlled ovarian
rates
controlled
Prior art date
Application number
BR0212429-7A
Other languages
English (en)
Inventor
Yves Menezo
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of BR0212429A publication Critical patent/BR0212429A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

"USO DE hCG NA HIPERESTIMULAçãO OVARIANA CONTROLADA". A presente invenção fornece um protocolo que leva a maiores taxas de implantação do embrião e/ou a menores taxas de abortos em que a hCG, ou um análogo biológico, é administrada durante a fase folicular.
BR0212429-7A 2001-09-12 2002-09-12 Uso de hcg na hiperestimulação ovariana controlada BR0212429A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01307757 2001-09-12
PCT/GB2002/004158 WO2003022302A2 (en) 2001-09-12 2002-09-12 USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION

Publications (1)

Publication Number Publication Date
BR0212429A true BR0212429A (pt) 2004-10-26

Family

ID=8182261

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0212429-7A BR0212429A (pt) 2001-09-12 2002-09-12 Uso de hcg na hiperestimulação ovariana controlada

Country Status (20)

Country Link
US (1) US7405197B2 (pt)
EP (1) EP1425032A2 (pt)
JP (1) JP2005501918A (pt)
KR (1) KR20040032954A (pt)
CN (1) CN100536912C (pt)
AR (1) AR036592A1 (pt)
BR (1) BR0212429A (pt)
CA (1) CA2457849A1 (pt)
EA (1) EA009330B1 (pt)
HK (1) HK1067867A1 (pt)
HR (1) HRP20040087A2 (pt)
IL (1) IL160780A0 (pt)
ME (1) MEP39208A (pt)
MX (1) MXPA04002256A (pt)
NO (1) NO20040991L (pt)
PL (1) PL369098A1 (pt)
RS (1) RS21004A (pt)
UA (1) UA82650C2 (pt)
WO (1) WO2003022302A2 (pt)
ZA (1) ZA200400835B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE416783T1 (de) * 2003-02-07 2008-12-15 Austria Wirtschaftsserv Gmbh Verwendung des menschlichen choriongonadotropins in der behandlung von endometriose-symptomen
US20040248784A1 (en) 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
US20150273020A1 (en) * 2007-05-11 2015-10-01 Lori R. Bernstein Hormone Normalization Therapy and Uses Therefor
EP2243423B1 (de) * 2009-04-23 2012-05-02 Roche Diagnostics GmbH Verfahren und Gerät zur Ermittlung von Empfehlungen für Wirkstoffdosierungen anhand von Messserien zumindest eines physiologischen Parameters eines Patienten
TWI532495B (zh) 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
CN103619358B (zh) 2011-03-31 2017-02-15 辉凌公司 药物制剂
US8680086B2 (en) 2011-04-15 2014-03-25 Neuralight Hd, Llc Methods for chronic pain management and treatment using HCG
US20120265129A1 (en) * 2011-04-15 2012-10-18 Neuralight Hd, Llc Methods for Chronic Pain Management and Treatment using HCG
RU2014103185A (ru) 2011-07-18 2015-08-27 Артс Байолоджикс А/С Биологически активное соединение на основе лютеинизирующего гормона (lh) с пролонгированным действием
US10271876B2 (en) 2011-11-23 2019-04-30 Mezadata Medical Ip Holding Llc Method of in vitro fertilization with delay of embryo transfer and use of peripheral blood mononuclear cells
WO2014063071A1 (en) 2012-10-18 2014-04-24 Neuralight Hd, Llc Treatment of depression and ptsd
WO2014159813A1 (en) 2013-03-13 2014-10-02 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
CA3031252A1 (en) 2016-07-21 2018-01-25 ObsEva S.A. Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage
CA3035055A1 (en) 2016-08-29 2018-03-08 Progena, Inc. Autologous somatic stem cell therapy, method of controllable preparation of therapeutic composition and procedure of adaptive treatment of ivf patient
RU2646578C1 (ru) * 2017-02-13 2018-03-05 Федеральное государственное бюджетное военное образовательное учреждение высшего образования Военно-медицинская академия им. С.М. Кирова Министерства обороны Российской Федерации (ВМедА) Способ повышения эффективности имплантации эмбриона в естественном цикле зачатия и в протоколах вспомогательных репродуктивных технологий
CN109431647B (zh) * 2018-09-20 2020-10-30 华中农业大学 一种杂交水牛同期发情-定时输精的处理方法
EP4025207A1 (en) 2019-09-03 2022-07-13 ObsEva S.A. Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage
US20230102503A1 (en) 2020-02-10 2023-03-30 ObsEva S.A. Biomarkers for oxytocin receptor antagonist therapy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4589402A (en) 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
US5705478A (en) * 1989-02-21 1998-01-06 Washington University Covalently linked β subunits of the glycoprotein hormones as antagonists
ES2247710T3 (es) 1997-06-20 2006-03-01 Akzo Nobel N.V. Antagonista de gonadotropina.
ZA987497B (en) 1997-09-08 1999-02-23 Akzo Nobel Nv Expression of gonadotropins in dictyostelium
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
KR20010093280A (ko) * 1999-02-24 2001-10-27 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 불임증 치료
CN1352566A (zh) * 1999-05-07 2002-06-05 应用研究系统Ars股份公司 促性腺激素
PT1250148E (pt) 2000-01-27 2004-09-30 Applied Research Systems Uso de fsh para o tratamento da infertilidade

Also Published As

Publication number Publication date
EA200400427A1 (ru) 2004-08-26
NO20040991L (no) 2004-03-08
CN100536912C (zh) 2009-09-09
AR036592A1 (es) 2004-09-22
US7405197B2 (en) 2008-07-29
WO2003022302A2 (en) 2003-03-20
HK1067867A1 (en) 2005-04-22
EA009330B1 (ru) 2007-12-28
WO2003022302A3 (en) 2003-12-18
UA82650C2 (uk) 2008-05-12
ZA200400835B (en) 2005-04-26
US20050065069A1 (en) 2005-03-24
JP2005501918A (ja) 2005-01-20
IL160780A0 (en) 2004-08-31
EP1425032A2 (en) 2004-06-09
KR20040032954A (ko) 2004-04-17
PL369098A1 (en) 2005-04-18
CA2457849A1 (en) 2003-03-20
HRP20040087A2 (en) 2004-12-31
CN1553808A (zh) 2004-12-08
RS21004A (en) 2006-12-15
MEP39208A (en) 2011-02-10
MXPA04002256A (es) 2004-07-23

Similar Documents

Publication Publication Date Title
BR0212429A (pt) Uso de hcg na hiperestimulação ovariana controlada
WO2002094169A3 (en) Back-mountable massage device
BR0213358A (pt) Uso de flibanserina
BR9812597A (pt) Aparelho de máscara facial, e, suporte para uma máscara facial
DE60143984D1 (de) Neue phenylalanin-derivate
BR0111358A (pt) Compostos de tioacetamida e seu uso
HUP0303656A3 (en) Modulators of bruton's tyrosine kinase, their identification and use
BR9913457A (pt) Neuroproteção
GB0211527D0 (en) Branch locking of job tickets to control concurrency
BR0010531A (pt) Composições e usos de et743 para tratamento de câncer
DE60123114D1 (de) Verpackungsmittel zur aufnahme einer blisterpackung
HK1067865A1 (en) Use of hcg and lh in controlled ovarian hyperstimulation
BR0213684A (pt) Uso de antagonistas do receptor de endotelina para o tratamento de doenças tumorìgenas
BR9909357A (pt) Solução ou suspensão de mirtazapina em mistura com água, formulação farmacêutica compreendendo mirtazapina, e, uso de mirtazapina
BR9811643A (pt) Suplementação quìmica de osso
ES2218407T3 (es) Uso de oxazolidinonas tiamida para el tratamiento de la resorcion osea y la osteoporosis.
ATE215941T1 (de) Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
HUP0202645A2 (hu) Ösztramusztin-foszfátot és albumint tartalmazó, parenteralis felhasználásra szolgáló készítmények
BR0206918A (pt) Uso de iloperidona
RU2001101249A (ru) Препарат для биологической стимуляции репродуктивной функции у свиноматок
AR019248A1 (es) Toalla sanitaria
BR0109157A (pt) Dispositivo concentrador
BG105422U (en) Preparation for pediculis humanis control
BR0102709A (pt) Disposição aplicada em talher oriental hashi
IT1317066B1 (it) Uso di derivati dell'acido cinnamico come agenti insetticidi.

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: LABORATOIRES SERONO S.A. (CH)

Free format text: TRANSFERIDO DE: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUI DADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2108 DE 31/05/2011.